Enveda · N/A · Unknown

Enveda raised a funding round that valued the AI biotech at $2 billion. The company is testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

AI-generated: summaries written by AI from the linked sources. How we use AI